Regulatory T-cells inhibit microglia-induced pain hypersensitivity in female mice

  1. Julia Kuhn
  2. Ilia D Vainchtein
  3. Joao M Braz
  4. Katherine Hamel
  5. Mollie Bernstein
  6. Veronica Craik
  7. Madelene W Dahlgren
  8. Jorge Ortiz-carpena
  9. Ari Molofsky
  10. Anna Molofsky  Is a corresponding author
  11. Allan Basbaum  Is a corresponding author
  1. University of California San Francisco, United States
  2. University of California, San Francisco, United States
  3. University California San Francisco, United States

Abstract

Peripheral nerve injury-induced neuropathic pain is a chronic and debilitating condition characterized by mechanical hypersensitivity. We previously identified microglial activation via release of colony stimulating factor 1 (CSF1) from injured sensory neurons as a mechanism contributing to nerve injury-induced pain. Here we show that intrathecal administration of CSF1, even in the absence of injury, is sufficient to induce pain behavior, but only in male mice. Transcriptional profiling and morphologic analyses after intrathecal CSF1 showed robust immune activation in male but not female microglia. CSF1 also induced marked expansion of lymphocytes within the spinal cord meninges, with preferential expansion of regulatory T-cells (Tregs) in female mice. Consistent with the hypothesis that Tregs actively suppress microglial activation in females, Treg deficient (Foxp3DTR) female mice showed increased CSF1-induced microglial activation and pain hypersensitivity equivalent to males. We conclude that sexual dimorphism in the contribution of microglia to pain results from Treg-mediated suppression of microglial activation and pain hypersensitivity in female mice.

Data availability

RNA sequencing data are available through GEO accession #GSE 184801All data generated or analysed during this study and required for conclusions to be drawn are included in the manuscript and supporting files.The upload can be identified at the following link: https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE184801

The following data sets were generated

Article and author information

Author details

  1. Julia Kuhn

    Anatomy, University of California San Francisco, San Francisco, United States
    Competing interests
    Julia Kuhn, Patent approved on use of CSF1 blockade to treat neuropathic pain (Publication Number WO/2016/057800)..
  2. Ilia D Vainchtein

    Psychiatry, University of California San Francisco, San Francisco, United States
    Competing interests
    No competing interests declared.
  3. Joao M Braz

    Anatomy, University of California, San Francisco, San Francisco, United States
    Competing interests
    No competing interests declared.
  4. Katherine Hamel

    Anatomy, University of California San Francisco, San Francisco, United States
    Competing interests
    No competing interests declared.
  5. Mollie Bernstein

    Anatomy, University of California, San Francisco, San Francisco, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-2327-5771
  6. Veronica Craik

    Anatomy, University of California, San Francisco, San Francisco, United States
    Competing interests
    No competing interests declared.
  7. Madelene W Dahlgren

    Laboratory Medicine, University California San Francisco, San Francisco, United States
    Competing interests
    No competing interests declared.
  8. Jorge Ortiz-carpena

    Laboratory Medicine, University of California San Francisco, San Francisco, United States
    Competing interests
    No competing interests declared.
  9. Ari Molofsky

    Laboratory Medicine, University of California San Francisco, San Francisco, United States
    Competing interests
    No competing interests declared.
  10. Anna Molofsky

    Laboratory Medicine, University of California San Francisco, San Francisco, United States
    For correspondence
    Anna.Molofsky@ucsf.edu
    Competing interests
    No competing interests declared.
  11. Allan Basbaum

    Anatomy, University of California San Francisco, San Francisco, United States
    For correspondence
    allan.basbaum@ucsf.edu
    Competing interests
    Allan Basbaum, Reviewing editor, eLifePatent approved on use of CSF1 blockade to treat neuropathic pain (Publication Number WO/2016/057800)..
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-1710-6333

Funding

National Institute of Neurological Disorders and Stroke (R35 NS097306)

  • Allan Basbaum

Open Philathropy

  • Allan Basbaum

Pew Charitable Trusts

  • Anna Molofsky

National Institute of Mental Health (R01MH119349)

  • Anna Molofsky

National Institute of Mental Health (DP2MH116507)

  • Anna Molofsky

Burroughs Wellcome Fund

  • Anna Molofsky

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: As noted in the description of the mice used in this study:"All mouse experiments were approved by UCSF Institutional Animal Care and Use Committee and conducted in accordance with the guidelines established by the Institutional Animal Care and Use Committee and Laboratory Animal Resource Center."Please note that this is a renewal that occurred during the course of the revision to the manuscript.APPROVAL NUMBER: AN183265-02DApproval Date: June 15, 2021Expiration Date: February 26, 2022

Copyright

© 2021, Kuhn et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,750
    views
  • 736
    downloads
  • 60
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Julia Kuhn
  2. Ilia D Vainchtein
  3. Joao M Braz
  4. Katherine Hamel
  5. Mollie Bernstein
  6. Veronica Craik
  7. Madelene W Dahlgren
  8. Jorge Ortiz-carpena
  9. Ari Molofsky
  10. Anna Molofsky
  11. Allan Basbaum
(2021)
Regulatory T-cells inhibit microglia-induced pain hypersensitivity in female mice
eLife 10:e69056.
https://doi.org/10.7554/eLife.69056

Share this article

https://doi.org/10.7554/eLife.69056

Further reading

    1. Neuroscience
    Gordon H Petty, Randy M Bruno
    Research Article

    Each sensory modality has its own primary and secondary thalamic nuclei. While the primary thalamic nuclei are well understood to relay sensory information from the periphery to the cortex, the role of secondary sensory nuclei is elusive. We trained head-fixed mice to attend to one sensory modality while ignoring a second modality, namely to attend to touch and ignore vision, or vice versa. Arrays were used to record simultaneously from the secondary somatosensory thalamus (POm) and secondary visual thalamus (LP). In mice trained to respond to tactile stimuli and ignore visual stimuli, POm was robustly activated by touch and largely unresponsive to visual stimuli. A different pattern was observed when mice were trained to respond to visual stimuli and ignore touch, with POm now more robustly activated during visual trials. This POm activity was not explained by differences in movements (i.e. whisking, licking, pupil dilation) resulting from the two tasks. Post hoc histological reconstruction of array tracks through POm revealed that subregions varied in their degree of plasticity. LP exhibited similar phenomena. We conclude that behavioral training reshapes activity in secondary thalamic nuclei. Secondary nuclei respond to the same behaviorally relevant, reward-predicting stimuli regardless of stimulus modality.

    1. Neuroscience
    Ji Eun Ryu, Kyu-Won Shim ... Eun Young Kim
    Research Article

    The circadian clock, an internal time-keeping system orchestrates 24 hr rhythms in physiology and behavior by regulating rhythmic transcription in cells. Astrocytes, the most abundant glial cells, play crucial roles in CNS functions, but the impact of the circadian clock on astrocyte functions remains largely unexplored. In this study, we identified 412 circadian rhythmic transcripts in cultured mouse cortical astrocytes through RNA sequencing. Gene Ontology analysis indicated that genes involved in Ca2+ homeostasis are under circadian control. Notably, Herpud1 (Herp) exhibited robust circadian rhythmicity at both mRNA and protein levels, a rhythm disrupted in astrocytes lacking the circadian transcription factor, BMAL1. HERP regulated endoplasmic reticulum (ER) Ca2+ release by modulating the degradation of inositol 1,4,5-trisphosphate receptors (ITPRs). ATP-stimulated ER Ca2+ release varied with the circadian phase, being more pronounced at subjective night phase, likely due to the rhythmic expression of ITPR2. Correspondingly, ATP-stimulated cytosolic Ca2+ increases were heightened at the subjective night phase. This rhythmic ER Ca2+ response led to circadian phase-dependent variations in the phosphorylation of Connexin 43 (Ser368) and gap junctional communication. Given the role of gap junction channel (GJC) in propagating Ca2+ signals, we suggest that this circadian regulation of ER Ca2+ responses could affect astrocytic modulation of synaptic activity according to the time of day. Overall, our study enhances the understanding of how the circadian clock influences astrocyte function in the CNS, shedding light on their potential role in daily variations of brain activity and health.